Ikram Nur K B K, Simonsen Henrik T
Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.
Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Front Plant Sci. 2017 Nov 15;8:1966. doi: 10.3389/fpls.2017.01966. eCollection 2017.
Malaria is still an eminent threat to major parts of the world population mainly in sub-Saharan Africa. Researchers around the world continuously seek novel solutions to either eliminate or treat the disease. Artemisinin, isolated from the Chinese medicinal herb , is the active ingredient in artemisinin-based combination therapies used to treat the disease. However, naturally artemisinin is produced in small quantities, which leads to a shortage of global supply. Due to its complex structure, it is difficult chemically synthesize. Thus to date, remains as the main commercial source of artemisinin. Current advances in genetic and metabolic engineering drives to more diverse approaches and developments on improving production of artemisinin, both in and in other plants. In this review, we describe efforts in bioengineering to obtain a higher production of artemisinin in and stable heterologous systems. The current progress and advancements provides hope for significantly improved production in plants.
疟疾仍然是对世界主要人口的一个重大威胁,主要集中在撒哈拉以南非洲地区。世界各地的研究人员不断寻求新的解决方案来消除或治疗这种疾病。从中国草药中分离出的青蒿素是用于治疗该疾病的青蒿素联合疗法中的活性成分。然而,天然青蒿素产量很低,导致全球供应短缺。由于其结构复杂,很难通过化学合成。因此,至今青蒿仍然是青蒿素的主要商业来源。基因和代谢工程的最新进展推动了在青蒿及其他植物中提高青蒿素产量的更多样化方法和发展。在这篇综述中,我们描述了在生物工程方面为在青蒿和稳定的异源系统中获得更高产量的青蒿素所做的努力。目前的进展为显著提高植物产量带来了希望。